Accu-Break Pharmaceuticals

Accu-Break Pharmaceuticals is a private drug delivery technology company founded in 1960 and headquartered in Hollywood (Fort Lauderdale area), Florida. The company's core asset is its ACCU-BREAK™ platform, a patented tablet design featuring an inactive break layer that allows for precise, safe splitting into fractional doses, addressing a significant need in personalized medicine, pediatrics, and geriatrics. Operating as a technology licensor, Accu-Break aims to partner with pharmaceutical companies to reformulate existing or pipeline drugs, offering them a pathway for product differentiation, lifecycle management, and potential patent extension. The company appears to be in a pre-revenue or early partnership stage, leveraging its management's extensive pharmaceutical industry experience to commercialize its platform.

ACCU-BREAK™ tablet design featuring a drug-free 'break layer' that allows tablets to be split accurately into halves, thirds, or quarters without compromising dose integrity. Applicable to both immediate-release and controlled-release formulations.

Accu-Break operates in the niche drug delivery technology space. Direct competitors may include other firms with tablet-splitting or dose-adjustment technologies, but its specific 'inactive break layer' design appears unique. Broader competition includes alternative delivery methods (liquids, patches) and the entrenched practice of conventional tablet splitting, which it aims to displace.